Seda Keskin Gökmen

Seda Keskin Gökmen

Auto-generated profile, based on publicly available information

Seda Keskin Gökmen

School Of Medicine, Department of Pathology, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2026 in Journal of Hematopathology
Verified
Journal Article
Closed access
PDF file
RHRabia Hurşitoğlu
Rabia Hurşitoğlu
ABAbdulkadir Yasir Bahar
Abdulkadir Yasir Bahar
SGSeda Keskin Gökmen
Seda Keskin Gökmen

15 March 2026 in Bozok Tıp Dergisi
Verified
Journal Article
Closed access
ABAbdulkadir Yasir Bahar
Abdulkadir Yasir Bahar
SGSeda Keskin Gökmen
Seda Keskin Gökmen
EKEmine Kılınç
Emine Kılınç
SGSelin Fitnet Görücü
Selin Fitnet Görücü
ÖGÖzge Duymaz Gümüştaş
Özge Duymaz Gümüştaş
RHRabia Hurşitoğlu
Rabia Hurşitoğlu
Background Epstein-Barr virus –associated gastric cancer is one of four molecular subtypes defined by the Cancer Genome Atlas Program. Epstein-Barr virus –associated gastric cancer incidence has ethnic and geographical differences. The aims of the present study were to investigate the frequency of EBV in gastric cancer tissues and adjacent non-tumoral epithelium. Materials and Methods EBV positivity was assessed by chromogenic EBER-ISH in tumor tissues of 101 patients who were diagnosed with gastric carcinoma and underwent gastrectomy in our center between January 2008 and August 2023. The link between EBV incidence in gastric cancer, survival and clinicopathological prognostic factors was statistically assessed. Results EBV was positive in tumor tissue in 6 of 101 (%5,9) cases. In addition, positive staining was detected in intestinal metaplasia areas adjacent to the tumor in 10 cases (9.9%) and in normal gastric mucosa adjacent to the tumor in 13 cases (12.9%). All 6 cases with EBV- associated gastric cancer were male, 4 had diffuse histological type and 3 were histological grade 3, 4 had lymph node metastases and 2 had distant metastases. No statistically significant correlation was found between EBER positivity and clinicopathological prognostic factors, except for male gender (p= 0.021). There was no statistical correlation between EBV positivity and survival. Conclusion The frequency of EBV- associated gastric cancer was 5.9% in our center. EBV positivity is also present in inflammatory cells, intestinal metaplasia and normal tissues adjacent to gastric carcinoma tissue.

26 June 2026
Verified
Book
Closed access
ZÇZüleyha Çetindağ
Züleyha Çetindağ
SESena Öztürk Efe
Sena Öztürk Efe
SASedanur Aydın
Sedanur Aydın
MÖMerve Öz
Merve Öz
SGSeda Keskin Gökmen
Seda Keskin Gökmen
TKTülay Koç
Tülay Koç

28 October 2026 in Polish Journal of Pathology
Verified
Journal Article
Open access
PDF file
SGSeda Keskin Gökmen
Seda Keskin Gökmen
EGEmine Kılınç Günay
Emine Kılınç Günay
ABAbdulkadir Yasir Bahar
Abdulkadir Yasir Bahar
RGRasim Gökmen
Rasim Gökmen
RHRabia Hursitoglu
Rabia Hursitoglu
C-C motif chemokine ligand 18 (CCL18), mainly produced by M2-polarised tumour-associated macrophages, is implicated in immunosuppression, invasion, and metastasis, whereas IgG4-positive plasma cells may reflect humoral immunoregulation and immune evasion. In this retrospective cohort study, stromal CCL18 expression at the primary tumour invasion front was evaluated in relation to overall survival in 76 patients with node-positive gastric adenocarcinoma. Stromal IgG4 was assessed secondarily, and concordance between primary tumours and matched lymph node metastases was examined. Immunohistochemical evaluation was restricted to the stromal compartment. IgG4 expression was defined as ≥ 10 positive plasma cells per high-power field, and CCL18 expression was dichotomised using study- specific median cut-offs. Median overall survival was shorter in patients with high vs. low primary tumour stromal CCL18 expression (9.3 vs. 23.2 months). In multivariable Cox regression adjusted for age, sex, histologic grade, and pathological stage, high primary tumour stromal CCL18 expression was associated with shorter overall survival; this association persisted after adding stromal IgG4 to the model. Primary tumour stromal IgG4 showed no independent survival association. Concordance was higher for IgG4 than for CCL18. These findings support primary tumour stromal CCL18 as a candidate tumour microenvironment marker associated with shorter overall survival in node-positive gastric adenocarcinoma.

26 June 2026
Verified
Book Chapter
Closed access
SGSeda Keskin Gökmen
Seda Keskin Gökmen
Bu kitap bölümünde yabancı cisim lenfadenopatisinin tanımı, patogenezi, klinik önemi, histopatolojik özellikleri ve ayırıcı tanısı ele alınmaktadır. Yabancı cisim lenfadenopatisi; eksojen veya endojen materyallerin lenfatik drenaj yoluyla lenf nodlarına taşınması ve histiyositik/yabancı cisim tipi inflamatuvar yanıt oluşturmasıyla gelişen reaktif bir lenf nodu patolojisidir. Bölümde proteinöz lenfadenopati, silikon lenfadenopatisi, eklem protezi ilişkili lenfadenopati, altın lenfadenopatisi, lipid lenfadenopatisi ve cerrahi materyal, dövme pigmenti, silika, kömür tozu gibi diğer yabancı cisim kaynaklı lenfadenopatiler sistematik olarak incelenmektedir. Her alt başlıkta etiyolojik faktörler, klinik yansımalar, mikroskobik bulgular, immünohistokimyasal özellikler ve tanısal ipuçları özetlenmiştir. Özellikle silikon implant, protez materyali veya malignite öyküsü bulunan hastalarda bu lezyonların metastatik karsinom, lenfoma, granülomatöz enfeksiyonlar ve diğer reaktif lenfadenopatilerle karışabileceği vurgulanmaktadır. Doğru tanı için klinik öykü, histopatolojik morfoloji, özel boyalar, polarize ışık incelemesi ve gerektiğinde ek analitik yöntemlerin birlikte değerlendirilmesi gereklidir. This book chapter discusses the definition, pathogenesis, clinical significance, histopathological features, and differential diagnosis of foreign body lymphadenopathy. Foreign body lymphadenopathy is a reactive lymph node pathology that develops when exogenous or endogenous materials are transported to lymph nodes via lymphatic drainage, triggering a histiocytic or foreign body–type inflammatory response. The chapter systematically reviews proteinaceous lymphadenopathy, silicone lymphadenopathy, prosthesis-associated lymphadenopathy, gold lymphadenopathy, lipid lymphadenopathy, and other foreign body–related lymphadenopathies caused by surgical materials, tattoo pigments, silica, and coal dust. For each entity, etiological factors, clinical manifestations, microscopic findings, immunohistochemical characteristics, and diagnostic clues are summarized. Particular emphasis is placed on the potential for these lesions to mimic metastatic carcinoma, lymphoma, granulomatous infections, and other reactive lymphadenopathies, especially in patients with a history of silicone implants, prosthetic materials, or malignancy. Accurate diagnosis requires comprehensive evaluation of clinical history, histopathological morphology, special stains, polarized light examination, and, when necessary, additional analytical methods.